...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

It's NOT!...confirmed multiple times by Sarah Z and the IR department of Zenith in Calgary.

Share
New Message
Please login to post a reply